Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vaccine offers hope in fight against major chicken disease
The recombinant vaccines have potential to be more cost-effective and respond to emerging new virus strains.
Researchers test effectiveness of recombinant virus vaccine

Researchers have developed a new vaccine strategy that could help chickens in the fight against infectious bronchitis.

Current vaccines that protect against infectious bronchitis guard against some strains of the virus, but not others. Scientists believe these failures are associated with differences in the spike protein - the protein which enables the virus to attach to and enter cells - between strains of the virus.

Writing in the Journal Of Virology, researchers describe how they tested a new approach using a specialist type of vaccine, known as recombinant virus vaccine. These vaccines use harmless or weak versions of a virus or bacteria to introduce microbes into cells into the body.

The team used recombinant viruses with different spike proteins as vaccines to build two versions of a harmless virus. They found that the vaccine offered partial protection against infectious bronchitis virus, but further research is needed to develop a more robust vaccine.

Researchers say the recombinant vaccines have potential to be more cost-effective and respond to emerging new virus strains. The next step will be to develop a vaccine that remains harmless but induces a stronger immune response.

Professor Lonneke Vervelde, who led the study at the University’s Roslin Institute, said: “There is a real need to develop new vaccines against infectious bronchitis that protect against multiple strains and offer rapid responses. We are trying to make a vaccine that offers broad protection, but further research is needed to develop a more robust vaccine.”

Dr Erica Bickerton at the Pirbright Institute, who also took part in the study, said: “Our research hopes to develop more cost-effective and efficient commercial vaccines that are capable of protecting chickens against this serious disease.”

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
RVC leads globally for Veterinary Science

The Royal Veterinary College (RVC) has retained its lead in Veterinary Science education in the QS World University Rankings 2025.

The college scored 100 for its Academic Reputation and increased its Employer Reputation to 91.7 points. It also maintained high scores for Citations per Paper and H-Index.

RVC says that its score recognises its students' employability and the institution's standing with employers. It also highlighted the impact that its graduates and alumni are making in the sector.

Stuart Reid CBE, president and principal of RVC, said: "We are dedicated to maintaining the teaching, learning and research that takes place at the RVC.

"I am delighted that the effort from all our staff and students has once again led to a great outcome in the QS rankings; it is a privilege we do not take for granted."

The full rankings can be found here.